Skip to main content
Clinical Trials/NCT04970459
NCT04970459
Recruiting
N/A

Constitution of a Biological Collection to Study the Pathophysiology in Marfan Syndrome and Related Syndromes and to Identify Predictive Factors of Disease Progression

University Hospital, Toulouse1 site in 1 country300 target enrollmentJanuary 24, 2022

Overview

Phase
N/A
Intervention
collection of samples of blood and urine
Conditions
Marfan Syndrome
Sponsor
University Hospital, Toulouse
Enrollment
300
Locations
1
Primary Endpoint
Constitution of a biological collection from patients with Marfan or related syndromes. Collection of samples at inclusion.
Status
Recruiting
Last Updated
last month

Overview

Brief Summary

The present study will establish a collection of biological samples from Marfan patients or with associated diseases to be used for research purposes only, with due respect for confidentiality.

Detailed Description

Marfan syndrome is an autosomal dominant disease (incidence 1/5000) characterized by ocular, cardiac and skeletal abnormalities. More recently, a decrease in fat and muscle mass has been demonstrated, associated with a decrease in exercise endurance, causing a significant deterioration in the quality of life. Little is known about the pathophysiology of these symptoms. Patients with Marfan syndrome or related diseases are followed at the children's hospital as part of the Rare Diseases Reference Centre (CRMR) for Marfan syndrome at the Toulouse University Hospital. During regular check-up visits, an extra sample of blood and urine will be collected and stored for research utilisation with the patient's consent. The ultimate objective of this collection is to provide available biological resources to facilitate the development of subsequent studies aimed at better characterizing the multisystemic disorders in Marfan syndrome, to understand the pathophysiology of the disease, and to identify biological factors that predict the severity and progression of the disease. The possibility of having systematically collected biological resources will make it possible to answer certain questions more quickly depending on the progress of research.

Registry
clinicaltrials.gov
Start Date
January 24, 2022
End Date
August 7, 2031
Last Updated
last month
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children aged at least 3 years old or adult with Marfan syndrome or related syndromes
  • Patients affiliated to or beneficiaries of a social security scheme
  • Patients able to receive information on the progress of the study and understand the information form to participate in the study. That implies to master the French language and not to be subject to a restriction of rights by the judicial authorities
  • Patients or legal representative who have given their consent to participate in the study (expression of no objection)

Exclusion Criteria

  • Patients subject to a legal protection measure (guardianship, curators, or safeguard of justice)
  • Pregnant or breastfeeding women

Arms & Interventions

Patients with Marfan syndrome or related syndromes

Children aged at least 3 years old or adult with Marfan syndrome or related syndromes

Intervention: collection of samples of blood and urine

Outcomes

Primary Outcomes

Constitution of a biological collection from patients with Marfan or related syndromes. Collection of samples at inclusion.

Time Frame: during the intervention/procedure/surgery

extra sample of blood and urine will be collected

Constitution of a biological collection from patients with Marfan or related syndromes.

Time Frame: Day 0

extra sample of blood and urine will be collected

Study Sites (1)

Loading locations...

Similar Trials